Clinical Trial Update: A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating bempegaldesleukin (NKTR-214) in combination with nivolumab in patients with metastatic or locally advanced sarcoma; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• NKTR-214 (bempegaldesleukin)
• nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: SARCOMA | Phase 2 | Status: ACTIVE_NOT_RECRUITING